Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
31 August 2015 |
Main ID: |
NCT02527902 |
Date of registration:
|
18/08/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy
|
Scientific title:
|
Autonomic Nervous System (ANS) Analysis According to Different Renal Function Stage in Immunoglobin A (IgA) Nephropathy |
Date of first enrolment:
|
January 2011 |
Target sample size:
|
12 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02527902 |
Study type:
|
Interventional |
Study design:
|
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
Phase:
|
N/A
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Eric Alamartine, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
CHU Saint-Etienne |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- diagnosis of IgNA biopsy-proven free, informed, express and written
Exclusion Criteria:
- IgNA secondary to Henoch-Schonlein purpura (HSP) or Systemic Lupus Erythematosus or
alcoholic cirrhosis
- current kidney transplantation
- Hypertension treated or not,
- Diseases interfering with ANS analysis: cardiac arrhythmia, beta-blocker therapy
- diabetes
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
IGA Glomerulonephritis
|
Intervention(s)
|
Device: Holter
|
Primary Outcome(s)
|
Standard deviation of all R-R intervals (SDNN)
[Time Frame: day 1]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|